NCGFX
Price
$65.29
Change
+$0.71 (+1.10%)
Updated
Dec 24 closing price
VTSMX
Price
$144.64
Change
+$1.55 (+1.08%)
Updated
Dec 24 closing price
Ad is loading...

NCGFX vs VTSMX

Header iconNCGFX vs VTSMX Comparison
Open Charts NCGFX vs VTSMXBanner chart's image
New Covenant Growth
Price$65.29
Change+$0.71 (+1.10%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx I
Price$144.64
Change+$1.55 (+1.08%)
VolumeN/A
CapitalizationN/A
NCGFX vs VTSMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NCGFX vs. VTSMX commentary
Dec 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NCGFX is a StrongBuy and VTSMX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VTSMX has more cash in the bank: 1.84T vs. NCGFX (563M). VTSMX pays higher dividends than NCGFX: VTSMX (1.26) vs NCGFX (0.74). NCGFX was incepted earlier than VTSMX: NCGFX (26 years) vs VTSMX (33 years). NCGFX is a more actively managed with annual turnover of: 7.00 vs. VTSMX (2.00). NCGFX has a lower initial minimum investment than VTSMX: NCGFX (500) vs VTSMX (3000). VTSMX annual gain was more profitable for investors over the last year : 25.71 vs. NCGFX (15.19). VTSMX return over 5 years is better than : 81.67 vs. NCGFX (50.32).
NCGFXVTSMXNCGFX / VTSMX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years33 years-
Gain YTD14.86525.35559%
Front LoadN/AN/A-
Min. Initial Investment500300017%
Min. Initial Investment IRAN/AN/A-
Net Assets563M1.84T0%
Annual Yield % from dividends0.741.2658%
Returns for 1 year15.1925.7159%
Returns for 3 years9.0124.2737%
Returns for 5 years50.3281.6762%
Returns for 10 years86.19186.9146%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK10.660.40
+3.90%
CleanSpark
GLW47.900.40
+0.84%
Corning
STEL28.770.11
+0.38%
Stellar Bancorp
MG8.77-0.12
-1.35%
Mistras Group
SABS4.10-0.18
-4.21%
SAB Biotherapeutics